Mainz, Germany – As COVID-19 continues to impact the globe, ORGENTEC is positioned and prepared to make sure that we continue our business during this difficult period.
All of our efforts are focused on continuously providing our customers with the diagnostic tools they need for their patients.
At ORGENTEC we have been monitoring COVID-19 since the beginning of the year and have been complying with all government-mandated prevention procedures. We have implemented several measures to protect our employees, like special hygiene provisions, extended and flexible working hours and a voluntary work from home policy where appropriate, to keep our company working.
We produce antigens for our assays in house at ORGENTEC and we also maintain a good safety stock of assay components as part of our manufacturing process. We also maintain and adhere to industry standard hygiene procedures during assay production.
The situation is rapidly changing from day to day and we are prepared to react to new developments, to continue with our business activities.About ORGENTEC
Headquartered in Mainz, Germany, ORGENTEC Diagnostika offers one of the industry’s most comprehensive portfolios in autoimmune diagnostics and cardiovascular diagnostics with additional strengths in infectious disease and organ function testing. Alegria®, the automated instrument for autoimmune and infectious disease serology enables labs to complete multiple assays and deliver faster results at minimum cost. With subsidiaries in Austria, Hungary, France, U.S. and China, as well as an established global network of distribution partners, ORGENTEC’s products are benefitting patients in over 100 countries around the world.
{text}